Protein Biotechnologies Inc., a San Diego, California based company, provides global pharmaceutical, biotechnology, government and academic institutions with human clinical specimen derivatives and high-throughput protein and tissue microarrays.
Protein Biotechnologies

With the largest collection of ready-to-use, clinically defined, pathology-validated human specimen derivatives on the market, Protein Biotechnologies facilitates biomedical research and drug discovery efforts for cancer, neurodegenerative diseases, cardiovascular diseases, diabetes / obesity and autoimmune disease research.

To facilitate high-throughput screening of human clinical specimens, Protein Biotechnologies provides its tissue lysate library on ready-to-use protein microarrays. And, for protein localization, immunohistochemical and in-situ hybridization studies, Protein Biotechnologies' tissue microarrays are an ideal method for studying multiple human cancer / normal tissues in a single assay.

July, 2013
Protein Biotechnologies products used in massive reverse-phase protein array screening project by Harvard group. Download Abstract PDF. http://www.nature.com/onc/journal/vaop/ncurrent/abs/onc2012378a.html
February 20, 2006
The Global Burdern of Cancer
Worldwide, approximately 10 million people are diagnosed with cancer annually and more than 6 million die of the disease every year. Currently, there are over 22 million cancer patients worldwide.